Concepedia

Marco Springer

MS

Statistics

Publications

9

Citations

326

H-Index

9

Active since

1993

Affiliations

Vaximm (Germany)(Current)

National Center for Tumor Diseases

Heidelberg University

Radboud University Nijmegen

Radboud University Medical Center

Marco Springer is an author at Vaximm (Germany) specializing in medicine, dermatology, and wound healing.

Top concepts

Publications per year

1993–2017

9

Publications

9

Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trial

Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Andreas G. Niethammer et al. · OncoImmunology · 2015 · 72 citations · Full text

A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer

Friedrich H. Schmitz-Winnenthal, Nicolas Hohmann, Thomas Schmidt et al. · OncoImmunology · 2017 · 71 citations · Full text

Double-blind, placebo-controlled first in human study to investigate an oral vaccine aimed to elicit an immune reaction against the VEGF-Receptor 2 in patients with stage IV and locally advanced pancreatic cancer

Andreas G. Niethammer, Heinz Lubenau, Gerd Mikus et al. · BMC Cancer · 2012 · 57 citations · Full text

A single administration of LFA-1 antibody confers prolonged allograft survival.

Althea Talento, Mai T. Nguyen, Timothy R. Blake et al. · PubMed · 1993 · 31 citations

, , +21

Repair of sheep long bone cortical defects filled with COLLOSS®, COLLOSS® E, OSSAPLAST®, and fresh iliac crest autograft

William E. Huffer, James J. Benedict, A. Simon Turner et al. · Journal of Biomedical Materials Research Part B Applied Biomaterials · 2007 · 30 citations · Full text

1–5 of 9